Utility of in vitro release testing (IVRT) to assess 'sameness' of 1% clotrimazole creams for use as a biowaiver
Abstract The October 2022 draft United States Food and Drug Administration (FDA) guidance presents an option of in vitro release test (IVRT) studies as a biowaiver for topical drug products submitted in abbreviated new drug applications (ANDAs). However, the product-specific guidance (PSG) for 1% cl...
Saved in:
Main Authors: | , , , |
---|---|
格式: | 图书 |
出版: |
SpringerOpen,
2023-11-01T00:00:00Z.
|
主题: | |
在线阅读: | Connect to this object online. |
标签: |
添加标签
没有标签, 成为第一个标记此记录!
|
因特网
Connect to this object online.3rd Floor Main Library
索引号: |
A1234.567 |
---|---|
复印件 1 | 可用 |